NFL Biosciences SAS (ALNFL) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.030x

Based on the latest financial reports, NFL Biosciences SAS (ALNFL) has a cash flow conversion efficiency ratio of 0.030x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€57.51K ≈ $67.24K USD) by net assets (€1.91 Million ≈ $2.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NFL Biosciences SAS market capitalisation for the company's overall valuation and market capitalisation.

NFL Biosciences SAS - Cash Flow Conversion Efficiency Trend (2020–2022)

This chart illustrates how NFL Biosciences SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NFL Biosciences SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NFL Biosciences SAS ranked by their cash flow conversion efficiency. See NFL Biosciences SAS (ALNFL) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Mustera Property Group Ltd AU:MPX	0.201x
High Coast Distillery AB ST:HIGHCO-B	0.005x
ExGen Resources Inc V:EXG	-0.168x
Art Nirman Limited NSE:ARTNIRMAN	0.004x
GOLDSTORM METALS CORP. F:B2U	-0.009x
Transkon Jaya Pt JK:TRJA	0.059x
Huadi International Group Co Ltd NASDAQ:HUDI	-0.053x
Electric Royalties Ltd V:ELEC	-0.027x

Annual Cash Flow Conversion Efficiency for NFL Biosciences SAS (2020–2022)

The table below shows the annual cash flow conversion efficiency of NFL Biosciences SAS from 2020 to 2022. View ALNFL share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	€844.00K ≈ $986.72K	€104.89K ≈ $122.63K	0.124x	+369.60%
2021-12-31	€3.29 Million ≈ $3.84 Million	€87.00K ≈ $101.71K	0.026x	-95.27%
2020-12-31	€150.03K ≈ $175.39K	€83.91K ≈ $98.10K	0.559x	--

About NFL Biosciences SAS

PA:ALNFL France Biotechnology

Market Cap

$10.90 Million

€9.33 Million EUR

Market Cap Rank

#26944 Global

#458 in France

Share Price

€0.74

Change (1 day)

+0.68%

52-Week Range

€0.73 - €1.65

All Time High

€4.75